检测血清酸溶性蛋白可用于良恶性肝病鉴别诊断

THE SIGNIFICANCE OF SERUM ASP LEVEL IN THE DIFFERENTIATION OF BENIGN OR MALIGNANT LIVER DISEASE

本文检测了70例健康人、36例肝硬化患者、34例肝炎患者和43例肝癌患者的血清ASP水平,结果分别为109.5±26.5;55.6±36.8;64.4±38.6和183.7±90.3mg/dl(X±SD)。实验证明检测血清ASP对良性肝病与恶性肝肿瘤的鉴别诊断具有一定意义。

The serum ASP level of 70 healthy subjects, 36 patients with liver cirrhosis, 34 patients with hepatitis and 43 patients with liver cancer have been measured. The results were 109.5±26.5; 55.6±36.8; 64±38.6 and 183.7±90.3mg/dl (±SD) respectively. The results demonstrated that the measurement of serum ASP and AFP are useful for the differentiation of benign or malignant liver diseases.